This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Huaxin Pharmaceutical Hong Kong 6.80% 2021-03 USD

New bond issue: Huaxin Pharmaceutical Hong Kong (HKSE:5297) issued new debt notes (XS1765322380) for 150M USD as of March 8, 2018.

Huaxin Pharmaceutical Hong Kong is a subsidiary of its Chinese parent company. Taizhou Huaxin Pharmaceutical Investment Co. Ltd. is a Chinese pharmaceutical company. Taizhou Huaxin is headquartered in Taizhou, China.

IssuerHuaxin Pharmaceutical Hong Kong
Stock (Group)HKSE:5297
Bond TypeCorporate
CategorySenior
Maturity DateMarch 15, 2021
Residual Duration3 months, 15 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)6.800%
Coupon FrequencySemiannual
Minimum Lot200,000 USD
Additional Lots1,000 USD
Issue DateMarch 15, 2018
Issued Amount150,000,000 USD
Maturity Price100.000%
Home ExchangeHong Kong
IsinXS1765322380
IndustryPharmaceuticals
SectorHealth Care
CountryHong Kong
RegionAsia Pacific developed


Bonds, Corporate, Health Care, Pharmaceuticals, Asia Pacific developed, Hong Kong, USD, Fixed Rate, Income


Next HDFC Bank FLR% 2021-03 USD

investopoli.com